|
1. Biologie
|
|
|
|
|
3.1 Tabac
|
|
|
|
4. Dépistage, diagnostic et pronostic
|
|
|
|
|
4.13 Dép., diag. & prono. - Peau
|
|
|
|
4.5 Dép., diag. & prono. - Colorectal
|
|
|
Exact Sciences Shares Dip After Company Adjusts Revenue Forecast [Xconomy]
|
|
|
|
|
|
Exact,
whose flagship product is a stool-based DNA screening test for
colorectal cancer known as Cologuard, said it completed about 68,000 of
the tests during the third quarter. The company reiterated its
projection that it would complete 240,000 tests of Cologuard this year;
hitting that target would require a fourth-quarter total of at least
78,000 tests.
|
|
|
|
|
|
|
5. Traitements
|
|
|
|
More Than Was Asked For [In the Pipeline]
|
|
|
|
|
|
Here’s
an interesting report from the New England Journal of Medicine. It
describes a patient diagnosed with follicular lymphoma who also was
positive for hepatitis C. They went through a course of Gilead’s
sofosbuvir with ribavirin, and that (as it usually does) cleared the Hep
C infection. What’s interesting is that at the end of the treatment the
lymphoma was in complete remission as well.
|
|
|
|
|
|
|
|
5.12 Immunothérapies
|
|
|
|
|
5.12.2 Immunothérapies - CAR-T
|
|
|
New approach to cancer treatment carries success with caveat [Harvard]
|
|
|
|
|
|
In
mice with chronic viral infection, exhausted T cells are controlled by a
fundamentally different set of molecular circuits than T cells
effectively battling infections or cancer. This finding suggests a way
to increase the staying power of CAR T cells, a promising form of
immunotherapy for cancer.
|
|
|
|
|
|
|
5.12.4 Immunothérapies - Essais
|
|
|
|
|
5.2.2 Pharma - Fusions & Acquisitions
|
|
|
|
|
5.4 Traitements - Economie
|
|
|
|
5.6 ESMO
|
|
|
ESMO Symposium on Immuno-Oncology 2016 [ESMO]
|
|
|
|
|
|
At
the ESMO Symposium on Immuno-Oncology starting Friday 4 November in
Lausanne, Switzerland, around 600 experts and researchers from all over
the world will gather to discuss advances in cancer immunotherapy, from
cancer vaccines to antibodies and cell therapies.
|
|
|
|
|
|
|
6.11 Patients
|
|
|
|
6.7 DMP, Big Data & applis
|
|
|
|
|
6.9 Controverses
|
|
|